|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the administration of opioid antagonists by a school |
|
nurse at public school campuses. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. The heading to Subchapter E, Chapter 38, |
|
Education Code, is amended to read as follows: |
|
SUBCHAPTER E. MAINTENANCE, [AND] ADMINISTRATION, AND DISPOSAL OF |
|
EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND OPIOID |
|
ANTAGONISTS |
|
SECTION 2. Section 38.201, Education Code, is amended by |
|
adding Subdivision (3-a) to read as follows: |
|
(3-a) "Opioid antagonist" and "opioid-related drug |
|
overdose" have the meanings assigned by Section 483.101, Health and |
|
Safety Code. |
|
SECTION 3. The heading to Section 38.208, Education Code, |
|
is amended to read as follows: |
|
Sec. 38.208. MAINTENANCE, [AND] ADMINISTRATION, AND |
|
DISPOSAL OF EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND |
|
OPIOID ANTAGONISTS. |
|
SECTION 4. Section 38.208, Education Code, is amended by |
|
adding Subsections (a-2) and (c-1) and amending Subsections (c) and |
|
(e) to read as follows: |
|
(a-2) Each school district and open-enrollment charter |
|
school shall adopt and implement a policy authorizing a school |
|
nurse to maintain, administer, and dispose of an opioid antagonist |
|
at each campus of the district or school. |
|
(c) The executive commissioner of the Health and Human |
|
Services Commission, in consultation with the commissioner of |
|
education, and with advice from the advisory committee as |
|
appropriate, shall adopt rules regarding: |
|
(1) the maintenance, administration, and disposal of |
|
an epinephrine auto-injector at a school campus subject to a policy |
|
adopted under Subsection (a); |
|
(2) [and] the maintenance and administration of asthma |
|
medicine at a school campus subject to a policy adopted under |
|
Subsection (a-1); and |
|
(3) the maintenance, administration, and disposal of |
|
an opioid antagonist at a school campus in accordance with a policy |
|
adopted under Subsection (a-2). |
|
(c-1) The rules adopted under Subsection (c) must |
|
establish: |
|
(1) the number of epinephrine auto-injectors |
|
available at each campus; |
|
(2) the amount of prescription asthma medicine |
|
available at each campus; |
|
(3) the amount and type of opioid antagonists |
|
available at each campus; |
|
(4) the process for a [each] school district, |
|
open-enrollment charter school, and private school, as applicable, |
|
to check the inventory of epinephrine auto-injectors, [and] asthma |
|
medicine, and opioid antagonists at regular intervals for |
|
expiration and replacement; and |
|
(5) [(4)] the amount of training required for school |
|
personnel and school volunteers to administer an epinephrine |
|
auto-injector. |
|
(e) The supply of epinephrine auto-injectors at each campus |
|
must be stored in a secure location and be easily accessible to |
|
school personnel and school volunteers authorized and trained to |
|
administer an epinephrine auto-injector. The supply of asthma |
|
medicine and opioid antagonists at each campus must be stored in a |
|
secure location and be easily accessible to the school nurse. |
|
SECTION 5. Section 38.209, Education Code, is amended to |
|
read as follows: |
|
Sec. 38.209. REPORT ON ADMINISTERING EPINEPHRINE |
|
AUTO-INJECTOR OR OPIOID ANTAGONIST. (a) Not later than the 10th |
|
business day after the date a school personnel member or school |
|
volunteer administers an epinephrine auto-injector in accordance |
|
with a policy adopted under Section 38.208(a), or a school nurse |
|
administers an opioid antagonist under Section 38.208(a-2), the |
|
school shall report the information required under Subsection (b) |
|
to: |
|
(1) the school district, the charter holder if the |
|
school is an open-enrollment charter school, or the governing body |
|
of the school if the school is a private school, as applicable; |
|
(2) the physician or other person who prescribed the |
|
epinephrine auto-injector or opioid antagonist; and |
|
(3) the commissioner of state health services. |
|
(b) The report required under this section must include the |
|
following information: |
|
(1) the age of the person who received the |
|
administration of the epinephrine auto-injector or opioid |
|
antagonist; |
|
(2) whether the person who received the administration |
|
of the epinephrine auto-injector or opioid antagonist was a |
|
student, a school personnel member or school volunteer, or a |
|
visitor, as applicable; |
|
(3) the physical location where the epinephrine |
|
auto-injector or opioid antagonist was administered; |
|
(4) the number of doses of epinephrine auto-injector |
|
or opioid antagonist administered; |
|
(5) the title of the person who administered the |
|
epinephrine auto-injector or opioid antagonist; and |
|
(6) any other information required by the commissioner |
|
of education. |
|
SECTION 6. The heading to Section 38.211, Education Code, |
|
is amended to read as follows: |
|
Sec. 38.211. PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS, |
|
[AND] ASTHMA MEDICINE, AND OPIOID ANTAGONISTS. |
|
SECTION 7. Sections 38.211(a), (b), (c), (e), and (f), |
|
Education Code, are amended to read as follows: |
|
(a) A physician or person who has been delegated |
|
prescriptive authority under Chapter 157, Occupations Code, may |
|
prescribe: |
|
(1) epinephrine auto-injectors or asthma medicine in |
|
the name of a school district, open-enrollment charter school, or |
|
private school; or |
|
(2) opioid antagonists in the name of a school |
|
district or open-enrollment charter school. |
|
(b) A physician or other person who prescribes epinephrine |
|
auto-injectors, [or] asthma medicine, or opioid antagonists under |
|
Subsection (a) shall provide the school district, open-enrollment |
|
charter school, or private school with a standing order for the |
|
administration of, as applicable: |
|
(1) an epinephrine auto-injector to a person |
|
reasonably believed to be experiencing anaphylaxis; [or] |
|
(2) asthma medicine to a person reasonably believed to |
|
be experiencing a symptom of asthma and who has provided written |
|
notification and permission as required by Section 38.208(b-1); or |
|
(3) an opioid antagonist to a person reasonably |
|
believed to be experiencing an opioid-related drug overdose. |
|
(c) The standing order under Subsection (b) is not required |
|
to be patient-specific, and the epinephrine auto-injector, [or] |
|
asthma medicine, or opioid antagonist may be administered to a |
|
person without a previously established physician-patient |
|
relationship. |
|
(e) An order issued under this section must contain: |
|
(1) the name and signature of the prescribing |
|
physician or other person; |
|
(2) the name of the school district, open-enrollment |
|
charter school, or private school to which the order is issued; |
|
(3) the quantity of epinephrine auto-injectors, [or] |
|
asthma medicine, or opioid antagonists to be obtained and |
|
maintained under the order; and |
|
(4) the date of issue. |
|
(f) A pharmacist may dispense, without requiring the name or |
|
any other identifying information relating to the user: |
|
(1) an epinephrine auto-injector or asthma medicine to |
|
a school district, open-enrollment charter school, or private |
|
school; or |
|
(2) an opioid antagonist to a school district or |
|
open-enrollment charter school [without requiring the name or any |
|
other identifying information relating to the user]. |
|
SECTION 8. Section 38.215(a), Education Code, is amended to |
|
read as follows: |
|
(a) A person who in good faith takes, or fails to take, any |
|
action under this subchapter is immune from civil or criminal |
|
liability or disciplinary action resulting from that action or |
|
failure to act, including: |
|
(1) issuing an order for epinephrine auto-injectors, |
|
[or] asthma medicine, or opioid antagonists; |
|
(2) supervising or delegating the administration of an |
|
epinephrine auto-injector or asthma medicine; |
|
(3) possessing, maintaining, storing, or disposing of |
|
an epinephrine auto-injector, [or] asthma medicine, or opioid |
|
antagonist; |
|
(4) prescribing an epinephrine auto-injector, [or] |
|
asthma medicine, or opioid antagonist; |
|
(5) dispensing: |
|
(A) an epinephrine auto-injector or opioid |
|
antagonist; or |
|
(B) asthma medicine, provided that permission |
|
has been granted as provided by Section 38.208(b-1); |
|
(6) administering, or assisting in administering: |
|
(A) [,] an epinephrine auto-injector or opioid |
|
antagonist; or |
|
(B) asthma medicine, provided that permission |
|
has been granted as provided by Section 38.208(b-1); |
|
(7) providing, or assisting in providing, training, |
|
consultation, or advice in the development, adoption, or |
|
implementation of policies, guidelines, rules, or plans; or |
|
(8) undertaking any other act permitted or required |
|
under this subchapter. |
|
SECTION 9. This Act applies beginning with the 2023-2024 |
|
school year. |
|
SECTION 10. This Act takes effect immediately if it |
|
receives a vote of two-thirds of all the members elected to each |
|
house, as provided by Section 39, Article III, Texas Constitution. |
|
If this Act does not receive the vote necessary for immediate |
|
effect, this Act takes effect September 1, 2023. |